Introduction
There can be little dispute that cellular proliferation is one of the most fundamental of biological processes.' Nor can there be disagreement over the importance of assessing cellular proliferation in the study of many biological processes: indeed, Leblond2 used such assessment for identifying the three major functional types of cellular populationnamely, static, conditional renewal, and continually renewing. The practice of histopathology involves direct or, more usually, indirect assessment of cellular proliferation (and related phenomena such as differentiation) in many situations.3 It is intended that this brief overview will illustrate current ideas about cellular proliferation and its regulation and the advantages and disadvantages of the better known methods for assessing cellular proliferation in histopathological material
The cell cycle The observations of Howard and Pelc, who used 32P incorporation and autoradiography during the early 1950s, led to the introduction of the concept of the cell cycle and its subdivision into several phases (figure).45 DNA synthesis and doubling of the genome take place during the synthetic or S phase. This is preceded by a period of variable duration known as the first gap (G,) phase which separates the S phase from the previous mitosis --CYCLING (M phase). The S phase is followed by a period of apparent inactivity known as the second gap phase (G2) which comes before the next mitosis. Interphase comprises successive G1, S, and G2 phases and forms the largest part of the cell cycle. Lajtha proposed that there is a further phase in the cell cycle (Go) in which cells are not part of the cell cycle but, after suitable stimuli, may rejoin the cycling population.6 Not all authors, however, are agreed on the nature of Go. In any tissue there are also cells that, for whatever reason, can no longer divide and so any cell population can be divided into a cycling and a non-cycling compartment.
This naturally leads to the definition of the proliferative or growth fraction of any cellular population as the ratio of cycling to cycling plus non-cycling cells.7 Although there is a great deal which remains unclear, large advances have been made in our understanding of the regulation of the eukaryotic cell cycle. At a simple phenomenological level molecules can be identified, especially proteins, whose functional state varies in synchrony with the cell cycle, either in protein level or in activity.8 9 In model systems such as yeast, cell cycle mutants can be identified by conventional and molecular genetic analyses, and these approaches have led to the cloning and sequencing of genes involved in the cell cycle. Biochemical methods have also been used to define enzymatic activities involved in various phases of the cell cycle, such as in DNA synthesis. The results of such strategies indicate that the molecular control of cellular proliferation has been remarkably conserved through evolution with similar regulatory mechanisms operating in all eukaryotes, with cascades of regulatory genes which seem to have a role in controlling cell division.9 10 For example, a key gene in yeast and in man encodes a 34 kilodalton protein kinase, essential for cell division, known as cdc2.`-3 The level of this protein does not change during the cell cycle but its functional activity does as a consequence of altered phosphorylation' 15; phosphorylation of target proteins, which changes their function, is a particularly prevalent regulatory mechanism in cell cycle control.
Other important cellular proteins involved directly or indirectly in the control of cell proliferation have been identified. For example, cyclins are a group of proteins (also known as proliferating cell nuclear antigens or PCNA), which accumulate progressively through interphase and disappear at the end of mitosis. These proteins are now known to be components of DNA polymerase ( and are essential for completion of the cell cycle.9 1617 These occur throughout eukaryotes, including plants.'8 Several histone proteins vary in synchrony with the cell cycle and could be suitable markers for assessing changes associated with cell proliferation.'9 The regulation of genes related to the cell cycle by specific promoter sequences is also now becoming better understood. 20 Finally, there seem to be specific genes associated with growth arrest in mammalin cells, although these are as yet only poorly characterised." 22 There seem to be numerous functionally interrelated substances that vary in level or activity during the cell cycle, whose functions (whether structural or regulatory) are to permit the initiation and completion of normal cell division. Against this background a variety of cellular changes can be identified which can be used to pinpoint cell proliferation in histological material. In simple terms, mitoses can be counted, the incorporation of nucleotides (or their analogues) into newly synthesised DNA during the S phase can be identified, and the varying levels of structural or functional moieties associated with different aspects of the cell cycle can be assayed. Antibodies have been raised to the products of several cell division cycle (cdc) genes in yeast and can detect the relevant protein in both biochemical assays and immunohistochemical preparations."023
Antibodies have been used to show the presence of cyclin/PCNA and other gene products related to the cell cycle such as DNA polymerase a. Many other cell cycle related proteins will also probably be useful in the histological assessment of cell proliferation or exit from the proliferative compartment.
Methods for assessing cellular proliferation
MITOSES
The mitotic phase of the cell cycle is the only part that can be recognised by simple morphological examination, and the reader is referred to standard texts for the classic morphological features of the mitotic cycle.'
As these features are so well described the assessment of cell proliferation by counting mitoses should be straightforward; this method is considered to provide useful information in many tumours such as lymphomas, 24 25 melanomas,26 soft tissue sarcomas,27 especially smooth muscle tumours.28 It is part of the grading system of several tumours, notably carcinoma of the breast.
Several potential problems must be considered in the use of mitoses as an indicator of proliferation. The Another approach to assessing cell proliferation is to take advantage of the process of DNA synthesis. A normal somatic cell has a diploid genome; DNA synthesis during S phase leads to a doubling of the genetic information and the cell becomes temporarily tetraploid. This process can be measured in several ways.
Thymidine labelling
The introduction of tritiated thymidine and the development of high resolution autoradiography during the 1950s led to the use of thymidine labelling as the "gold standard" for cell kinetic studies. The method requires viable cells to take up tritiated thymidine and for this to be incorporated into DNA during the S phase. It consequently requires the in vivo administration of radiolabelled thymidine which can rarely be justified in clinical practice. Alternatively, biopsy and other specimens must be incubated with tritiated thymidine for some time in vitro before fixation. Both of these restraints militate against thymidine labelling as a practical routine procedure for histopathologists. In some centres, however, thymidine labelling has been extensively used on clinical material from a wide range of conditions,34-36 particularly lymphomas37-39 and breast carcin- Bromodeoxyuridine incorporation Synthesis of DNA can also be assessed by measuring the incorporation of a thymidine analogue such as bromodeoxyuridine. This molecule can then be detected by specific antibodies,4950 either in tissue sections or by flow cytometry,5051 and used for detailed cell cycle analysis52 as with thymidine incorporation. The disadvantages are similar to those of tritiated thymidine, in particular the need for in vivo administration or in vitro incubation. Ethical permission for some in vivo studies has been obtained, however, and in vitro incubation of biopsy or other surgical specimens is feasible."'.
Flow cytometry
The capacity of some dyes to bind to DNA in a stoichiometric manner means that the amount of DNA present in a nucleus can be determined, at least in comparison with some reference standard. The method of static cytometry has been widely used to investigate the relative DNA content of cells, but only relatively limited information can be obtained and that relates to ploidy rather than proliferation itself. Considerably more information can be obtained using flow cytometry in which large numbers of cells are analysed and appropriate statistical methods applied to the resulting data to give information about DNA content and cell cycle variables. The most important disadvantages of flow cytometry include the cost of the equipment required, the need to disrupt tissues so that the spatial relation of cellular subpopulations is lost, and the possible inclusion ofadmixed nonneoplastic cells in samples. On the other hand, the information obtained is objective and represents measurements on very large numbers of cells, in contrast to most of the other methods described for the investigation of cell proliferation.
IMMUNOHISTOCHEMICAL METHODS
As well as their use in the immunohistochemical demonstration of bromodeoxyuridine, antibodies have become an important means of assessing cell proliferation. A particular advantage is that the immunohistological demonstration of cell cycle related antigens allows spatial orientation to be shown, and the phenotype of proliferating cells can be determined by double staining methods. C5F10, an antibody, which recognises cells in mitosis has been described90 but this has been found to cross-react with many other cellular components and offers few advantages over conventional assessment of mitoses in histological sections (P A Hall, unpublished observations).
Perhaps the best known antibody that recognises proliferating cells is Ki67. This identifies a poorly characterised nuclear antigen associated with the cell cycle, being expressed in all phases except GO.9" 92 Recent studies using a variety of techniques, including confocal microscopy, suggest that the antigen is a component of the nuclear matrix. 133 134 Another approach has been to use antibodies that recognise some component of the cellular DNA replication machinery such as DNA polymerase a, which is transcriptionally regulated in a cell cycle dependent manner. "15 This enzyme can be recognised in cytological and histological material by monoclonal antibodies,'36 137 and these have been successfully applied to a variety of clinical specimens, including lymphomas.138 139 Other authors have proposed that the immunohistological demonstration of transferrin receptor (CD71) can be used as an index of cellular proliferation and can provide useful clinical information, at least in non-Hodgkin's lymphoma.14 The transferrin receptor is expressed widely, not only on proliferating tissues but also on those that are non-proliferating but metabolically active,14' and is thus a poor index of cellular proliferation. 142 Autoantibodies which react with nuclear antigens in proliferating cells are found in some patients with connective tissue diseases, and the possibility that they may be useful biological markers for the study ofproliferating cells has been recognised for some time. 143 144 One particular group of autoantibodies recognises cyclin/PCNA. ' 
Quantitation
Irrespective of the method used for the assessment of cell proliferation, it is important to consider how it should be quantitated. Flow cytometry analyses very large numbers of cells, but considerably fewer are generally examined in the other methods. For the immunohistochemical assessment of proliferation, some authors have used manual counting of cells on tissue sections, and this may be very time consuming as many cells must be counted.'09 113 121 There is no absolute answer to the question, how many cells need to be counted? In fact, the more pertinent question is how many cells need to be counted to be able to distinguish confidently between two values? This topic is well reviewed elsewhere. 176178 An alternative is to use a semiquantitative method and this seems to give reproducible results.119 121 178 Image analysis techniques have also been successfully applied to sections and fine needle aspirates immunostained with Ki67. 15 179 180 Heterogeneity within a specimen must also be considered, particularly in tumours:35 113 Several methods can be used to obtain information about proliferative rates.3536 77 These include metaphase arrest or stathmokinetic methods to determine the rate of mitosis, or labelling methods using pulses of thymidine and multiple biopsy specimens, double labelling or continuous labelling methods, and the fraction of labelled mitosis technique. These complex and time consuming methods are rarely practical in clinical material due to the need for the in vivo administration of toxic substances or the need for in vitro incubations. They also require multiple biopsy specimens in most cases. Thornton, however, has recently reported the application of a double labelling method, with both thymidine and bromodeoxyuridine incorporation, for the measurement of the S phase duration in endometrial biopsy specimens,'89 and other studies of clinical material have been reported. Differences within and between tumours in the duration of the cell cycle may also be of clinical importance, yet are not shown by simple "state" measurements. 35 Cell loss is also an important component of the kinetic state of tissue, including tumours, but this is difficult to quantify.35 190 The assessment of numbers of apoptotic bodies provides an index of the state of cell death, but information on rate of cell death is more difficult to obtain.'9' Loss of cells from the proliferative compartment-for example, by differentiation-is also difficult to assess.
Conclusions and prospects
The assessment of cellular proliferation in histological material is a valuable component of conventional histopathological analysis, and a variety of methods can be used to quantify this. Ideally such methods should be simple, reproducible, and applicable to conventionally processed histological and cytological preparations. The method should be relatively inexpensive and interpretation of the results should be straightforward. Many of the different methods described in this review measure slightly different variables, and although comparable, the data produced are not identical. It is always useful to consider the nature of the biological process being used as an index of proliferation. With 
